*  Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer - Full Text View - ClinicalTrials.gov
Paclitaxel. Gemcitabine. Cisplatin. Bevacizumab. Carboplatin. Erlotinib Hydrochloride. Pemetrexed. Antineoplastic Agents, ... Non-squamous carcinoma: pemetrexed + cisplatin or paclitaxel + carboplatin +/- bevacizumab. *Squamous carcinoma: gemcitabine + ...
  https://clinicaltrials.gov/ct2/show/study/NCT01383148?view=record
*  S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer - Full Text...
Paclitaxel. Albumin-Bound Paclitaxel. Carboplatin. Erlotinib Hydrochloride. Antineoplastic Agents, Phytogenic. Antineoplastic ... S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer. This study is ... Patients receive paclitaxel IV over 3 hours and carboplatin IV over 30 minutes on day 1 and oral erlotinib hydrochloride once ... Drug Information available for: Paclitaxel Carboplatin Erlotinib hydrochloride Erlotinib Genetic and Rare Diseases Information ...
  https://clinicaltrials.gov/ct2/show/NCT00661193?term=S0709&rank=1
*  Weekly Paclitaxel Plus Carboplatin in Preoperative Treatment of Breast Cancer - Full Text View - ClinicalTrials.gov
4 cycles of neoadjuvant paclitaxel plus carboplatin. Drug: Paclitaxel, Carboplatin Paclitaxel 80 mg/m2, carboplatin AUC of 2 mg ... Paclitaxel. Albumin-Bound Paclitaxel. Carboplatin. Antineoplastic Agents, Phytogenic. Antineoplastic Agents. Tubulin Modulators ... Weekly Paclitaxel Plus Carboplatin in Preoperative Treatment of Breast Cancer. The safety and scientific validity of this study ... Paclitaxel combined with carboplatin has shown great activity in ovarian and nonsmall- cell lung cancer treatment. In addition ...
  https://clinicaltrials.gov/ct2/show/NCT01203267
*  Phase II Study of Genasense-Carboplatin-Paclitaxel-combination in Uveal Melanoma
... carboplatin, and paclitaxel (GCP) can help to control metastatic uveal melanoma. The safety of this combination will also be ... The goal of this clinical research is to learn if the combination of Genasense (oblimersen), carboplatin, and paclitaxel (GCP) ... To evaluate objective response rate of patients with metastatic uveal melanoma to Genasense-Carboplatin-Paclitaxel (GCP) ...
  https://www.mdanderson.org/patients-family/diagnosis-treatment/clinical-trials/clinical-trials-index/clinical-trials-detail.ID2010-0188.html
*  BKM120 + Carboplatin + Paclitaxel for Patients With Advanced Solid Tumors
... added to standard chemotherapy with carboplatin and paclitax ... A Phase I Study of BKM120 + Carboplatin + Paclitaxel for ... steroids as premedications and anti-emetics for paclitaxel and carboplatin, per MSKCC. guidelines, is allowed). Steroids given ... for patients with advanced solid tumors, BKM120 in combination with two different schedules of paclitaxel and carboplatin. ... A Phase I Study of BKM120 + Carboplatin + Paclitaxel for Patients With Advanced Solid Tumors ...
  http://www.knowcancer.com/cancer-trials/NCT01297452/
*  BKM120 + Carboplatin + Paclitaxel for Patients With Advanced Solid Tumors - Full Text View - ClinicalTrials.gov
... carboplatin Drug: BKM120 (days 1-21) + paclitaxel (day 1) + carboplatin (day 1) Drug: BKM120, Paclitaxel + Carboplatin Phase 1 ... plus carboplatin and paclitaxel in PTEN deficient tumors and with dose intensified carboplatin and paclitaxel. Invest New Drugs ... Drug: BKM120, Paclitaxel + Carboplatin BKM120 100 mg per oral, days 1 - 21 Paclitaxel (175 mg/m2) intravenously on Day 1 ... Paclitaxel. Albumin-Bound Paclitaxel. Carboplatin. Antineoplastic Agents, Phytogenic. Antineoplastic Agents. Tubulin Modulators ...
  https://clinicaltrials.gov/ct2/show/study/NCT01297452
*  BKM120 + Carboplatin + Paclitaxel for Patients With Advanced Solid Tumors - Full Text View - ClinicalTrials.gov
... carboplatin Drug: BKM120 (days 1-21) + paclitaxel (day 1) + carboplatin (day 1) Drug: BKM120, Paclitaxel + Carboplatin Phase 1 ... Drug: BKM120, Paclitaxel + Carboplatin BKM120 100 mg per oral, days 1 - 21 Paclitaxel (175 mg/m2) intravenously on Day 1 ... Paclitaxel. Albumin-Bound Paclitaxel. Carboplatin. Antineoplastic Agents, Phytogenic. Antineoplastic Agents. Tubulin Modulators ... Drug: BKM120 days 1 - 21 plus paclitaxel + carboplatin Drug: BKM120 (days 1 - 28, ) plus paclitaxel + ...
  https://clinicaltrials.gov/show/NCT01297452
*  Paclitaxel & carboplatin - Information and support - Macmillan Cancer Support
If you or someone close to you has been diagnosed with cancer, you're not alone. Find out what to expect, get information, practical advice and support, hear from experts and read about other people's experiences.
  https://www.macmillan.org.uk/information-and-support/lung-cancer/small-cell-lung-cancer/treating/chemotherapy/drugs-and-combination-regimens/combination-chemotherapy/paclitaxel-and-carboplatin.html
*  Bevacizumab Study With Carboplatin & Paclitaxel in Ovarian, Fallopian Tube or Primary Peritoneal Cancer - Study Results -...
Carboplatin AUC 6 iv; Cycle two through six - Paclitaxel 175 mg/m2 iv; Carboplatin AUC 6 iv; Avastin 15 mg/kg IV Repeat cycle ... Carboplatin AUC 6 iv; Cycle two through six - Paclitaxel 175 mg/m2 iv; Carboplatin AUC 6 iv; Avastin 15 mg/kg IV Repeat cycle ... Bevacizumab Study With Carboplatin & Paclitaxel in Ovarian, Fallopian Tube or Primary Peritoneal Cancer. The safety and ... Bevacizumab Plus Carboplatin and Paclitaxel. This is a single Arm study. Two of the study drugs used are non-experimental. One ...
  https://clinicaltrials.gov/ct2/show/results/NCT00408070
*  Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer - Full Text View -...
Active Comparator: Carboplatin/Paclitaxel Chemotherapy. Drug: Carboplatin/Paclitaxel Paclitaxel 175 mg/m2 will administered ... Paclitaxel. Albumin-Bound Paclitaxel. Carboplatin. Trastuzumab. Antineoplastic Agents, Phytogenic. Antineoplastic Agents. ... to paclitaxel and carboplatin chemotherapy improves progression free survival when compared to paclitaxel and carboplatin alone ... Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer. This study is ongoing, ...
  https://clinicaltrials.gov/ct2/show/NCT01367002?recr=Open&cond=%22Endometrial+Neoplasms%22&rank=11
*  Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma - Full Text View - ClinicalTrials.gov
Experimental: Paclitaxel, carboplatin, erlotinib Carboplatin and paclitaxel IV every 21 days x 6 cycles plus oral erlotinib ... Erlotinib added to carboplatin and paclitaxel as first-line treatment of ovarian cancer: a phase II study based on surgical ... Patients receive paclitaxel IV over 3 hours and carboplatin IV over 30 minutes on day 1. Patients also receive oral erlotinib ... Drug Information available for: Paclitaxel Carboplatin Erlotinib hydrochloride Erlotinib Genetic and Rare Diseases Information ...
  https://clinicaltrials.gov/ct2/show/NCT00059787?cond=%22Adenocarcinoma+of+the+appendix%22&rank=12
*  A Phase I/II Study Afatinib/Carboplatin/Paclitaxel Induction Chemotherapy In HPV-Negative HNSCC. - Full Text View -...
Paclitaxel. Albumin-Bound Paclitaxel. Cisplatin. Carboplatin. Antineoplastic Agents, Phytogenic. Antineoplastic Agents. Tubulin ... A Phase I/II Study Afatinib/Carboplatin/Paclitaxel Induction Chemotherapy In HPV-Negative HNSCC.. This study has been completed ... Drug: Afatinib Drug: Paclitaxel Drug: Carboplatin Drug: Cisplatin Radiation: Intensity Modulated Radiation Therapy Phase 1 ... This will be followed immediately by 2 cycles of induction chemotherapy (IC) with carboplatin AUC 6 IV Day 1, paclitaxel 175mg/ ...
  https://clinicaltrials.gov/ct2/show/NCT01732640?cond=%22Squamous+cell+carcinoma+of+the+head+and+neck%22&rank=18
*  Carboplatin/Paclitaxel Appears To Be as Effective as Cisplatin/Paclitaxel in Ovarian Cancer | Cancer Network | The Oncology...
... paclitaxel as first-line treatment in ovarian cancer found significantly less toxicity with carboplatin/paclitaxel, with no ... either cisplatin/paclitaxel or carboplatin/paclitaxel. Paclitaxel. (185 mg/m²) was given as a 3-hour infusion. Cisplatin was ... between cisplatin/paclitaxel and carboplatin/paclitaxel.. To date, he said, there have been 253 events in GOG-158, an. ... Carboplatin/Paclitaxel Appears To Be as Effective as Cisplatin/Paclitaxel in Ovarian Cancer ...
  http://www.cancernetwork.com/articles/carboplatinpaclitaxel-appears-be-effective-cisplatinpaclitaxel-ovarian-cancer
*  Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer - Full Text View -...
Paclitaxel. Albumin-Bound Paclitaxel. Carboplatin. Antineoplastic Agents, Phytogenic. Antineoplastic Agents. Tubulin Modulators ... Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer. This study has been ... The purpose of this trial is to study the efficacy and safety of the triplet combination of TLK286, carboplatin and paclitaxel ... Phase 1-2a Dose-Ranging Study of the Triplet Combination of Carboplatin, Paclitaxel and TLK286 as First-Line Therapy in ...
  https://clinicaltrials.gov/ct2/show/NCT00088556
*  Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary...
Paclitaxel. Albumin-Bound Paclitaxel. Carboplatin. Antineoplastic Agents, Phytogenic. Antineoplastic Agents. Tubulin Modulators ... Drug Information available for: Paclitaxel Carboplatin Genetic and Rare Diseases Information Center resources: Ovarian Cancer ... Patients receive paclitaxel intravenously (IV) over 3 hours and carboplatin IV over 30 minutes on day 1. Treatment repeats ... Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary ...
  https://clinicaltrials.gov/ct2/show/NCT00331422
*  Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck...
Phase II Trial of Carboplatin/Paclitaxel and Cetuximab, Followed by Carboplatin/Paclitaxel/Cetuximab and Erlotinib, With ... Drug Information available for: Paclitaxel Carboplatin Erlotinib hydrochloride Erlotinib Cetuximab Genetic and Rare Diseases ... Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck ... Drugs used in chemotherapy, such as carboplatin and paclitaxel, work in different ways to stop the growth of tumor cells, ...
  https://clinicaltrials.gov/ct2/show/NCT01316757
*  Dose Escalating Study With BAY43-9006 With Carboplatin, Paclitaxel and Bevacizumab in Untreated Stage IIIb Non-small Cell Lung...
Paclitaxel. Sorafenib. Albumin-Bound Paclitaxel. Bevacizumab. Carboplatin. Niacinamide. Antineoplastic Agents, Phytogenic. ... Drug: Nexavar (Sorafenib, BAY43-9006) Drug: Bevacizumab Drug: Paclitaxel Drug: Carboplatin Phase 1 ... Dose Escalating Study With BAY43-9006 With Carboplatin, Paclitaxel and Bevacizumab in Untreated Stage IIIb Non-small Cell Lung ... Study of BAY43-9006 (Sorafenib) in Combination With Carboplatin, Paclitaxel and Bevacizumab in Previously Untreated Patients ...
  https://clinicaltrials.gov/show/NCT01069328
*  ISRCTN - ISRCTN23516549: CIRCCa (Cediranib In Recurrent Cervical Cancer): a trial of carboplatin-paclitaxel plus cediranib...
CIRCCa (Cediranib In Recurrent Cervical Cancer): a trial of carboplatin-paclitaxel plus cediranib versus carboplatin-paclitaxel ... a randomised double-blind phase II trial of carboplatin-paclitaxel plus cediranib versus carboplatin-paclitaxel plus placebo in ... Cediranib, carboplatin, paclitaxel Primary outcome measures. Progression free survival. Prior to progression patients will be ... The trial arm (Arm B) is carboplatin AUC 5 and paclitaxel 175 mg/m^2 infused intravenously over 3 hours, repeated every 3 weeks ...
  http://www.isrctn.com/ISRCTN23516549
*  Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With...
Active Comparator: Arm I (paclitaxel, docetaxel, carboplatin) Patients receive paclitaxel IV over 3 hours or docetaxel IV over ... Experimental: Arm II (paclitaxel, docetaxel, carboplatin, bevacizumab) Patients receive chemotherapy as in arm I and ... Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With ... Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With ...
  https://clinicaltrials.gov/ct2/show/record/NCT00565851
*  Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With...
Active Comparator: Arm I (paclitaxel, docetaxel, carboplatin) Patients receive paclitaxel IV over 3 hours or docetaxel IV over ... Drug Information available for: Paclitaxel Carboplatin Gemcitabine Gemcitabine hydrochloride Bevacizumab Genetic and Rare ... Experimental: Arm II (paclitaxel, docetaxel, carboplatin, bevacizumab) Patients receive chemotherapy as in arm I and ... Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With ...
  https://clinicaltrials.gov/ct2/show/NCT00565851?term=GOG+0213&rank=1
*  A Phase II Study of Using Panitumumab/Carboplatin/Paclitaxel (PaCT) Followed by Anthracycline-Containing Regimen (AC) for New...
A Randomized Phase II Study of Neoadjuvant Carboplatin/Paclitaxel (CT) Versus Panitumumab/Carboplatin/Paclitaxel (PaCT) ... Paclitaxel. Liposomal doxorubicin. Albumin-Bound Paclitaxel. Cyclophosphamide. Carboplatin. Doxorubicin. Antibodies, Monoclonal ... Paclitaxel given by vein on Days 1, 8, and 15 of Cycles 1-4. Carboplatin given by vein on Day 1 of Cycles 1-4. Panitumumab by ... Paclitaxel given by vein on Days 1, 8, and 15 of Cycles 1-4. Carboplatin given by vein on Day 1 of Cycles 1-4. ...
  https://clinicaltrials.gov/ct2/show/NCT02876107?term=inflammatory+breast+cancer&rank=31
*  Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilisib in Previously...
Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilisib in Previously ... Randomized Study Evaluating the Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and ... placebo-controlled trial will evaluate the efficacy and safety of carboplatin/paclitaxel and carboplatin/paclitaxel/bevacizumab ... Paclitaxel. Albumin-Bound Paclitaxel. Bevacizumab. Carboplatin. Antineoplastic Agents, Phytogenic. Antineoplastic Agents. ...
  https://clinicaltrials.gov/ct2/show/study/NCT01493843
*  A Study of Atezolizumab in Combination With Carboplatin Plus (+) Paclitaxel With or Without Bevacizumab Compared With...
Paclitaxel), Arm B (Atezolizumab+Carboplatin+Paclitaxel+Bevacizumab), or Arm C (Carboplatin+Paclitaxel+Bevacizumab). ... in combination with carboplatin+paclitaxel with or without bevacizumab compared with treatment with carboplatin+paclitaxel+ ... Paclitaxel. Atezolizumab. Albumin-Bound Paclitaxel. Bevacizumab. Carboplatin. Antibodies. Immunoglobulins. Antibodies, ... Paclitaxel With or Without Bevacizumab Compared With Carboplatin+Paclitaxel+Bevacizumab in Participants With Stage IV Non- ...
  https://clinicaltrials.gov/ct2/show/NCT02366143?term=29436&rank=1